Intravitreal Avastin in Proliferative Retinopathies

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study intends to assess the effect of Avastin injections in different proliferative retinopathies due to different causes

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ophthalmological Association Edelweiss
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• clinical diagnosis of a proliferative retinopathy (AGE RELATED MACULAR DEGENERATION,DIABETIC PROLIFERATIVE RETINOPATHY, etc)

• distance acuity < 0.5

• age > 20 years

Exclusion Criteria:

• noncooperative patients

• ocular infections / inflammations